Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases?

被引:48
作者
Burkhardt, Birgit [1 ,2 ]
机构
[1] Univ Hosp Schleswig Holstein, Dept Paediat, D-24105 Kiel, Germany
[2] Univ Giessen, Dept Paediat Haematol & Oncol, NHL BFM Study Ctr, Giessen, Germany
关键词
precursor T-cell; lymphoblastic lymphoma; lymphoblastic leukaemia; MINIMAL RESIDUAL DISEASE; CLINICAL-SIGNIFICANCE; LONG-TERM; GENE-EXPRESSION; CYTOGENETIC ABNORMALITIES; PROGNOSTIC-SIGNIFICANCE; NOTCH1; MUTATIONS; CRANIAL RADIOTHERAPY; INVERSE CORRELATION; FLOW-CYTOMETRY;
D O I
10.1111/j.1365-2141.2009.08006.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>There is ongoing discussion on whether paediatric acute T-cell lymphoblastic leukaemia (T-ALL) and paediatric lymphoblastic T-cell lymphoma (T-LBL) are two distinct entities or whether they represent two variant manifestations of one and the same disease and the distinction is arbitrary. Both show overlapping clinical, morphological and immunophenotypic features. Many clinical trials use the amount of blast infiltration of the bone marrow as the sole criterion to distinguish between T-ALL and T-LBL. The current World Health Organization classification designates both malignancies as T lymphoblastic leukaemia/lymphoma. However, subtle immunophenotypic, molecular and cytogenetic differences suggest that T-ALL and T-LBL might be biologically different in certain aspects. The current review summarizes and discusses the recent advances and understanding of the molecular profile of paediatric T-ALL and T-LBL.
引用
收藏
页码:653 / 668
页数:16
相关论文
共 108 条
[31]   Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia [J].
Flohr, T. ;
Schrauder, A. ;
Cazzaniga, G. ;
Panzer-Gruemayer, R. ;
van der Velden, V. ;
Fischer, S. ;
Stanulla, M. ;
Basso, G. ;
Niggli, F. K. ;
Schaefer, B. W. ;
Sutton, R. ;
Koehler, R. ;
Zimmermann, M. ;
Valsecchi, M. G. ;
Gadner, H. ;
Masera, G. ;
Schrappe, M. ;
van Dongen, J. J. M. ;
Biondi, A. ;
Bartram, C. R. .
LEUKEMIA, 2008, 22 (04) :771-782
[32]  
Foroni L, 2003, BLOOD, V102, p606A
[33]   Cell surface antigens in leukemias and lymphomas [J].
Freedman, AS .
CANCER INVESTIGATION, 1996, 14 (03) :252-276
[34]   The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group [J].
Gedman, A. Larson ;
Chen, Q. ;
Desmoulin, S. Kugel ;
Ge, Y. ;
LaFiura, K. ;
Haska, C. L. ;
Cherian, C. ;
Devidas, M. ;
Linda, S. B. ;
Taub, J. W. ;
Matherly, L. H. .
LEUKEMIA, 2009, 23 (08) :1417-1425
[35]   Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience [J].
Goldberg, JM ;
Silverman, LB ;
Levy, DE ;
Dalton, VK ;
Gelber, RD ;
Lehmann, L ;
Cohen, HJ ;
Sallan, SE ;
Asselin, BL .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3616-3622
[36]  
HARRIS NL, 1994, BLOOD, V84, P1361
[37]  
HAYASHI Y, 1990, BLOOD, V76, P1626
[38]  
HEAD DR, 1995, SEMIN DIAGN PATHOL, V12, P325
[39]   Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: A report from the children's cancer group [J].
Heerema, NA ;
Sather, HN ;
Sensel, MG ;
Kraft, P ;
Nachman, JB ;
Steinherz, PG ;
Lange, BJ ;
Hutchinson, RS ;
Reaman, GH ;
Trigg, ME ;
Arthur, DC ;
Gaynon, PS ;
Uckun, FM .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1270-1278
[40]   Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group [J].
Heerema, NA ;
Sather, HN ;
Sensel, MG ;
Lee, MK ;
Hutchinson, R ;
Lange, BJ ;
Bostrom, BC ;
Nachman, JB ;
Steinherz, PG ;
Gaynon, PS ;
Uckun, FM .
LEUKEMIA & LYMPHOMA, 2000, 36 (5-6) :467-478